| Erica Elise Hjelmstad, | |
|
2111 Landmark Cir, B, Minot, ND 58703-1967 | |
| (701) 839-4102 | |
| (701) 838-9603 |
| Full Name | Erica Elise Hjelmstad |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 2111 Landmark Cir, Minot, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215385349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1951 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| 360 Physical Therapy | 8921404658 | 4 |
News Archive
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.
The widespread view that terrorists are isolated, vulnerable young men with paranoid or borderline personality disorders, is false. It is entirely perpetuated by experts relying on second hand reports, he told the conference.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
At the American Association of Physicists in Medicine (AAPM) Annual Meeting yesterday, Russell J. Hamilton, PhD, Professor and Physics Section Head, University of Arizona Department of Radiation Oncology, reviewed dosimetry data for a minimally invasive episcleral brachytherapy device developed by Salutaris Medical Devices, Inc. (SalutarisMD) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes.
› Verified 7 days ago
| Provider Name | First Choice Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013098797 PECOS PAC ID: 7911994314 Enrollment ID: O20040428000348 |
News Archive
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.
The widespread view that terrorists are isolated, vulnerable young men with paranoid or borderline personality disorders, is false. It is entirely perpetuated by experts relying on second hand reports, he told the conference.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
At the American Association of Physicists in Medicine (AAPM) Annual Meeting yesterday, Russell J. Hamilton, PhD, Professor and Physics Section Head, University of Arizona Department of Radiation Oncology, reviewed dosimetry data for a minimally invasive episcleral brachytherapy device developed by Salutaris Medical Devices, Inc. (SalutarisMD) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes.
› Verified 7 days ago
| Provider Name | 360 Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1801463013 PECOS PAC ID: 8921404658 Enrollment ID: O20211027003149 |
News Archive
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.
The widespread view that terrorists are isolated, vulnerable young men with paranoid or borderline personality disorders, is false. It is entirely perpetuated by experts relying on second hand reports, he told the conference.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
At the American Association of Physicists in Medicine (AAPM) Annual Meeting yesterday, Russell J. Hamilton, PhD, Professor and Physics Section Head, University of Arizona Department of Radiation Oncology, reviewed dosimetry data for a minimally invasive episcleral brachytherapy device developed by Salutaris Medical Devices, Inc. (SalutarisMD) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erica Elise Hjelmstad, 2111 Landmark Cir, B, Minot, ND 58703-1967 Ph: (701) 839-4102 | Erica Elise Hjelmstad, 2111 Landmark Cir, B, Minot, ND 58703-1967 Ph: (701) 839-4102 |
News Archive
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy.
The widespread view that terrorists are isolated, vulnerable young men with paranoid or borderline personality disorders, is false. It is entirely perpetuated by experts relying on second hand reports, he told the conference.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
At the American Association of Physicists in Medicine (AAPM) Annual Meeting yesterday, Russell J. Hamilton, PhD, Professor and Physics Section Head, University of Arizona Department of Radiation Oncology, reviewed dosimetry data for a minimally invasive episcleral brachytherapy device developed by Salutaris Medical Devices, Inc. (SalutarisMD) to treat Wet AMD (Age-related Macular Degeneration), the leading cause of vision loss and blindness.
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive treatment typically hinges on a set of lab tests to identify genetic changes.
› Verified 7 days ago
First Choice Physical Therapy, Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2111 Landmark Cir, Suite B, Minot, ND 58703 Phone: 701-839-4102 Fax: 701-838-9603 | |
Kayla R Lambrecht, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2111 Landmark Cir Nw # B, Minot, ND 58703 Phone: 701-839-4102 | |
Jessica Fossen, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 3rd Ave Sw, Minot, ND 58701 Phone: 701-857-5286 Fax: 701-857-5694 | |
Aundrea Riehl, PT/DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 3rd Ave Sw, Minot, ND 58701 Phone: 701-857-5286 Fax: 701-857-5694 | |
Mrs. Patricia A Gerszewski, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 2nd St Se, Minot, ND 58701 Phone: 701-857-4410 | |
Mrs. Aimee Christine Clemens, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Burdick Expy W, Minot, ND 58701 Phone: 701-857-5105 Fax: 701-857-5646 | |
Hayley Lynn Carlson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2080 36th Ave Sw Ste 110, Minot, ND 58701 Phone: 701-222-3175 Fax: 701-222-3186 |